| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Feb 21, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 48.8 | -2,055 | -0.57% | ✗ | $42.9K |
| Jan 15, 2025 | Jan 17, 2025 | Immunovant, Inc. | Chief Medical Officer | Sell | 45.0 | -2,383 | -0.66% | ✗ | $56.8K |
| Nov 20, 2024 | Nov 22, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 45.0 | -3,353 | -0.92% | ✗ | $85.3K |
| Oct 16, 2024 | Oct 18, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 45.0 | -3,188 | -0.87% | ✗ | $91.8K |
| Aug 21, 2024 | Aug 23, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 45.0 | -3,027 | -0.82% | ✗ | $96.4K |
| Jul 17, 2024 | Jul 19, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 45.0 | -3,044 | -0.81% | ✗ | $90.4K |
| May 22, 2024 | May 24, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 45.0 | -3,247 | -0.86% | ✗ | $96.3K |
| Apr 17, 2024 | Apr 19, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 42.5 | -8,280 | -2.15% | ✗ | $240.6K |
| Feb 22, 2024 | Feb 23, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 45.0 | -2,221 | -0.67% | ✗ | $80.3K |
| Jan 18, 2024 | Jan 19, 2024 | Immunovant, Inc. | Chief Medical Officer | Sell | 51.3 | -424 | -0.13% | ✗ | $17.4K |
| Nov 22, 2023 | Nov 24, 2023 | Immunovant, Inc. | Chief Medical Officer | Sell | 45.0 | -3,265 | -0.97% | ✗ | $107K |
| Oct 19, 2023 | Oct 20, 2023 | Immunovant, Inc. | Chief Medical Officer | Sell | 51.3 | -530 | -0.16% | ✗ | $19.5K |
| Aug 24, 2023 | Aug 25, 2023 | Immunovant, Inc. | Chief Medical Officer | Sell | 40.0 | -12,333 | -3.53% | ✗ | $250.4K |
| Jul 19, 2023 | Jul 20, 2023 | Immunovant, Inc. | Chief Medical Officer | Sell | 51.3 | -426 | -0.12% | ✗ | $10.6K |
| Apr 25, 2023 | Apr 26, 2023 | Immunovant, Inc. | Chief Medical Officer | Sell | 52.5 | -509 | -0.15% | ✗ | $8.3K |
| Feb 2, 2023 | Feb 3, 2023 | Immunovant, Inc. | Chief Medical Officer | Sell | 52.5 | -537 | -0.20% | ✗ | $9.8K |
| Jan 11, 2023 | Jan 13, 2023 | Immunovant, Inc. | Chief Medical Officer | Sell | 40.0 | -44,568 | -14.47% | ✗ | $746.3K |
| Oct 21, 2022 | Oct 25, 2022 | Immunovant, Inc. | Chief Medical Officer | Sell | 52.5 | -341 | -0.11% | ✗ | $3.3K |
| Jul 22, 2022 | Jul 26, 2022 | Immunovant, Inc. | Chief Medical Officer | Sell | 52.5 | -322 | -0.16% | ✗ | $1.5K |
| Apr 19, 2022 | Apr 20, 2022 | Immunovant, Inc. | Chief Medical Officer | Sell | 50.0 | -1,392 | -0.71% | ✗ | $6.9K |
| Jan 5, 2022 | Jan 7, 2022 | Immunovant, Inc. | Chief Medical Officer | Sell | 42.5 | -26,813 | -11.96% | ✗ | $222K |